Murty pharmaceuticals INC:1109350 [19-002398]
Ended Awarded Last action
- Contract number
- 75N95019F00088
- Awardee
-
Murty Pharmaceuticals, Inc. UEI DNJBTJ3XBQM6
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $145,728
Award facts
- Opportunity
-
- CRO Support for NCATS Drug Product Development, Manufacture, and Stability Studies Pre-Solicitation · N01TR172003 · Posted Jul 21, 2016
- Contract value 100% obligated
- $145,728.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$75,192 | |
| Funding Only Action | -$145,728 | |
| Other Administrative Action | $0 | |
| Original award | $366,648 |
About this award
Murty Pharmaceuticals, Inc. was awarded a $145,728 firm fixed price delivery order contract by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA). The contract is not set aside and is part of the NCATS Drug Product Development Studies 2017-2022 indefinite delivery, indefinite quantity (IDIQ) contract vehicle. Under this task order, Murty Pharmaceuticals will provide drug product development, scale up, stability testing, and production services to support NIDA's substance abuse and addiction treatment research programs. This includes conducting current Good Manufacturing Practice (cGMP) manufacturing, quality control testing, and stability assessments for morphine sulfate pellets and methamphetamine hydrochloride. Murty Pharmaceuticals is a minority-owned, small disadvantaged business specializing in pharmaceutical research and commercial manufacturing.
Quick answers
Who was awarded contract 75N95019F00088?
75N95019F00088 was awarded to Murty Pharmaceuticals, Inc. by National Institute on Drug Abuse (National Institutes of Health) on March 15, 2019.
How much is contract 75N95019F00088 worth?
The government has obligated $145,728 on 75N95019F00088.
Is contract 75N95019F00088 an order under another contract?
Yes. 75N95019F00088 is a delivery order under HHSN271201700021I, an indefinite delivery contract, on NCATS Drug Product Development Studies 2017-2022.
Was contract 75N95019F00088 competed?
The extent of competition for 75N95019F00088 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award